Search results
What's the Difference Between Ozempic and Metformin, and Which One Is Right for You?
Parade via Yahoo News· 6 hours agoCost Price is a significant differentiating factor between the two. "Metformin is generally...
Taysha Gene Therapies Inc [TSHA] Insider Activity: An Update for Investors – Knox Daily
Knox Daily· 3 days agoB now holds 16,466,667 shares, worth roughly $56.48 million. Piper Sandler initiated its Taysha Gene Therapies Inc [TSHA] rating to an Overweight in a research note published ...
Repare (RPTX) Up 14% as Ovarian Cancer Combo Gets Fast Track Tag
Zacks via Yahoo Finance· 7 hours agoRepare (RPTX) rises 14% as the FDA grants Fast Track designation to its investigational...
India Has Low-Cost CAR T-Cell Therapy: Can US Follow Suit?
Medscape· 16 hours agoDr Maurie Markman discusses a news report on decreasing the cost of CAR-T therapy and the potential...
What Is 'Slow Shopping'?
HuffPost Life via Yahoo News· 11 hours agoFreeing yourself from this harmful social media cycle is just one of many potential mental health benefits from slow shopping. In contrast to “retail ...
How Laser Hair Therapy Reverses Thinning Hair! Plus the Best at-Home Devices to Use
First for Women via Yahoo News· 6 days agoTo learn more about laser hair therapy and determine if it's right for you, watch the below video...
Ultragenyx shares target raised, keeps Buy rating on successful outcome By Investing.com
Investing.com· 6 days agoPharmaceutical (NASDAQ:RARE) Inc. shares (NASDAQ:RARE), raising the price target to $111 from the...
East Lyme police chief charged in domestic violence incident
The Day· 20 hours agoEast Lyme ― Police Chief Michael Finkelstein has been suspended with pay following his arrest late...
Monopar Therapeutics COO buys $23,049 in company stock By Investing.com
Investing.com· 6 days agoOver the course of three days, Cittadine acquired a total of 36,000 shares of Monopar Therapeutics...
FDA advisors reject MDMA therapy for PTSD, amid concerns over research
MPR News· 1 day agoIt represents a major setback for proponents of the drug and its sponsor Lykos Therapeutics, potentially jeopardizing FDA approval of the treatment. Following public comment and discussion, ...
